232 related articles for article (PubMed ID: 29464314)
41. Raised circulating tenascin-C in rheumatoid arthritis.
Page TH; Charles PJ; Piccinini AM; Nicolaidou V; Taylor PC; Midwood KS
Arthritis Res Ther; 2012 Nov; 14(6):R260. PubMed ID: 23193984
[TBL] [Abstract][Full Text] [Related]
42. Early rheumatoid arthritis in a patient with Sjögren's syndrome and pulmonary nodular amyloidosis: clinical implication of early limited use of infliximab.
Mori S; Koga Y; Imamura F; Cho I; Sugimoto M
Mod Rheumatol; 2007; 17(6):500-6. PubMed ID: 18084704
[TBL] [Abstract][Full Text] [Related]
43. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
Elkayam O; Bashkin A; Mandelboim M; Litinsky I; Comaheshter D; Levartovsky D; Mendelson E; Wigler I; Caspi D; Paran D
Semin Arthritis Rheum; 2010 Jun; 39(6):442-7. PubMed ID: 19246078
[TBL] [Abstract][Full Text] [Related]
44. A relationship between pharmacokinetics (PK) and the efficacy of infliximab for patients with rheumatoid arthritis: characterization of infliximab-resistant cases and PK-based modified therapy.
Mori S
Mod Rheumatol; 2007; 17(2):83-91. PubMed ID: 17437161
[TBL] [Abstract][Full Text] [Related]
45. Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis.
Kageyama Y; Kobayashi H; Kato N
Mod Rheumatol; 2009; 19(6):657-62. PubMed ID: 19685204
[TBL] [Abstract][Full Text] [Related]
46. Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: an open, randomized, controlled trial.
Kurasawa T; Nagasawa H; Kishimoto M; Amano K; Takeuchi T; Kameda H
Mod Rheumatol; 2014 Jul; 24(4):561-6. PubMed ID: 24252035
[TBL] [Abstract][Full Text] [Related]
47. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
[TBL] [Abstract][Full Text] [Related]
48. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
[TBL] [Abstract][Full Text] [Related]
49. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis.
Abe T; Takeuchi T; Miyasaka N; Hashimoto H; Kondo H; Ichikawa Y; Nagaya I
J Rheumatol; 2006 Jan; 33(1):37-44. PubMed ID: 16395748
[TBL] [Abstract][Full Text] [Related]
50. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
[TBL] [Abstract][Full Text] [Related]
51. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis.
Kopp S; Alstergren P; Ernestam S; Nordahl S; Morin P; Bratt J
Cells Tissues Organs; 2005; 180(1):22-30. PubMed ID: 16088130
[TBL] [Abstract][Full Text] [Related]
52. Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis.
den Broeder AA; Wanten GJ; Oyen WJ; Naber T; van Riel PL; Barrera P
J Rheumatol; 2003 Feb; 30(2):232-7. PubMed ID: 12563673
[TBL] [Abstract][Full Text] [Related]
53. Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab.
Wiland P; Wiela-Hojenska A; Glowska A; Chlebicki A; Hurkacz M; Orzechowska-Juzwenko K; Szechinski J
Clin Exp Rheumatol; 2004; 22(4):469-72. PubMed ID: 15301246
[TBL] [Abstract][Full Text] [Related]
54. Rheumatoid peripheral blood phagocytes are primed for activation but have impaired Fc-mediated generation of reactive oxygen species.
Fairhurst AM; Wallace PK; Jawad AS; Goulding NJ
Arthritis Res Ther; 2007; 9(2):R29. PubMed ID: 17355628
[TBL] [Abstract][Full Text] [Related]
55. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.
van der Kooij SM; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Güler-Yüksel M; Zwinderman AH; Kerstens PJ; van der Lubbe PA; de Beus WM; Grillet BA; Ronday HK; Huizinga TW; Breedveld FC; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2009 Jun; 68(6):914-21. PubMed ID: 18662933
[TBL] [Abstract][Full Text] [Related]
56. Decreased ex vivo production of TNF-alpha and IL-8 by peripheral blood cells of patients with rheumatoid arthritis after infliximab therapy.
Lun SW; Wong CK; Tam LS; Li EK; Lam CW
Int Immunopharmacol; 2007 Dec; 7(13):1668-77. PubMed ID: 17996676
[TBL] [Abstract][Full Text] [Related]
57. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
Visvanathan S; Keenan GF; Baker DG; Levinson AI; Wagner CL
J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
[TBL] [Abstract][Full Text] [Related]
58. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
Gonzalez-Gay MA; Garcia-Unzueta MT; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
Clin Exp Rheumatol; 2006; 24(4):373-9. PubMed ID: 16956426
[TBL] [Abstract][Full Text] [Related]
59. Glucose-6-phosphate isomerase is associated with disease activity and declines in response to infliximab treatment in rheumatoid arthritis.
Xu J; Zhang XY; Li R; Liu J; Ye H; Zhang XW; Li ZG
Chin Med J (Engl); 2020 Apr; 133(8):886-891. PubMed ID: 32187052
[TBL] [Abstract][Full Text] [Related]
60. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
